Atlas Packaging appoints Operations Director Atlas Packaging appoints Operations Director Graham Campbell joins the UK firm from Ribble Packaging Theradiag appoints new Vice Presidents for business units Theradiag appoints new Vice Presidents for business units To lead the In vitro Diagnostics and Theranostics divisions, respectively Columbia Laboratories names new directors Columbia Laboratories names new directors Appointments follow recent acquisition of Molecular Profiles Freeman Technology appoints Product Manager Freeman Technology appoints Product Manager Direct company presence will strengthen support across Central Europe Janet Kelly joins SNBL USA to broaden firm\'s European reach Janet Kelly joins SNBL USA to broaden firm\'s European reach Takes over the role of Director of Business Development Midatech appoints Dr Jim Phillips as Chief Executive Midatech appoints Dr Jim Phillips as Chief Executive Brings more than 25 years of senior management and board level experience in public and private companies across Europe, the US and Australia Phil Lake to head Theorem biopharmaceutical franchise in respiratory Phil Lake to head Theorem biopharmaceutical franchise in respiratory Has remit to build respiratory business of American firm globally Dr Tom Shepherd joins BIOASTER as Chief Executive Dr Tom Shepherd joins BIOASTER as Chief Executive He has more than 30 years of experience in the life science industry Catalent appoints first President of Asia Pacific region Catalent appoints first President of Asia Pacific region Also names new President for Softgel Technologies business unit Apceth names Stefanos Theoharis as Chief Business Officer Apceth names Stefanos Theoharis as Chief Business Officer He will lead Apceth’s business development AMRI makes executive leadership changes AMRI makes executive leadership changes Thomas D\'Ambra to retire as President and CEO; to be succeeded by William Marth Amakem hires Jean Marie Stassen as Vice President, Research and Development Amakem hires Jean Marie Stassen as Vice President, Research and Development Co-founder Dirk Leysen steps down from his role as Chief Scientific Officer Biocartis strengthens management team Biocartis strengthens management team With the appointment of Ulrik Cordes as Chief Commercial Officer Novasep adds Christian Thiry as Chief Financial Officer Novasep adds Christian Thiry as Chief Financial Officer A key milestone in Novasep\'s senior management recruitment programme University of Warwick wins first Domainex Discovery STAR Award University of Warwick wins first Domainex Discovery STAR Award To support the search for a new treatment for Chagas disease Kymab appoints Christian Groendahl as Chief Executive Kymab appoints Christian Groendahl as Chief Executive While David Chiswell becomes Chairman Peter Belden named General Manager of PCI Rockford plant Peter Belden named General Manager of PCI Rockford plant Brings over 25 years of experience to the role EGA appoints new Director General EGA appoints new Director General Adrian van den Hoven takes up the role Disability charity\'s partner welcomes former US President Disability charity\'s partner welcomes former US President George and Laura Bush visit community rehabilitation centre in Tanzania Aesica creates position of Corporate Services Director Aesica creates position of Corporate Services Director Will oversee group-wide services of IT, M&A process planning, health and safety and internal audit system Coperion has a new President and Chairman of the executive board Coperion has a new President and Chairman of the executive board Board member Thomas Kehl takes up the role Rotronic opens branch office in Singapore Rotronic opens branch office in Singapore Sinna Sinnathurai has been appointed as Asia Sales Director Winning comes to GXPi Winning comes to GXPi Richard Winning becomes Clinical and Regulatory Project Manager at UK regulatory compliance specialist Ambrx hires Peter Kiener as Chief Scientific Officer Ambrx hires Peter Kiener as Chief Scientific Officer Brings expertise in development of next-generation biologic therapeutics to US firm